{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:15:39Z","timestamp":1790972139724,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971982"],"award-info":[{"award-number":["81971982"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2020C03046"],"award-info":[{"award-number":["2020C03046"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13081-0","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T07:03:18Z","timestamp":1729839798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of molecular subtypes based on bile acid metabolism in cholangiocarcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Mingxia","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"issue":"3","key":"13081_CR1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","volume":"77","author":"C Raggi","year":"2022","unstructured":"Raggi C, Taddei ML, Rae C, Braconi C, Marra F. Metabolic reprogramming in cholangiocarcinoma. J Hepatol. 2022;77(3):849\u201364. https:\/\/doi.org\/10.1016\/j.jhep.2022.04.038.","journal-title":"J Hepatol"},{"issue":"1","key":"13081_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hep.31410","volume":"73","author":"L Fabris","year":"2021","unstructured":"Fabris L, Sato K, Alpini G, Strazzabosco M. The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology. 2021;73(1):75\u201385. https:\/\/doi.org\/10.1002\/hep.31410.","journal-title":"Hepatology"},{"issue":"9","key":"13081_CR3","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1158\/1078-0432.CCR-21-1157","volume":"28","author":"S Chen","year":"2022","unstructured":"Chen S, Xie Y, Cai Y, Hu H, He M, Liu L, et al. Multiomic analysis reveals Comprehensive Tumor heterogeneity and distinct Immune subtypes in Multifocal Intrahepatic Cholangiocarcinoma. Clin Cancer Res. 2022;28(9):1896\u2013910. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-1157.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"13081_CR4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","volume":"75","author":"L Ma","year":"2021","unstructured":"Ma L, Wang L, Khatib SA, Chang CW, Heinrich S, Dominguez DA, et al. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol. 2021;75(6):1397\u2013408. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.028.","journal-title":"J Hepatol"},{"issue":"3","key":"13081_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3350\/cmh.2021.0287","volume":"28","author":"M Komuta","year":"2022","unstructured":"Komuta M. Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance. Clin Mol Hepatol. 2022;28(3):396\u2013407. https:\/\/doi.org\/10.3350\/cmh.2021.0287.","journal-title":"Clin Mol Hepatol"},{"issue":"9","key":"13081_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388. https:\/\/doi.org\/10.1038\/s41575-020-0310-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"13081_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/19490976.2019.1674124","volume":"11","author":"JA Winston","year":"2020","unstructured":"Winston JA, Theriot CM. Diversification of host bile acids by members of the gut microbiota. Gut Microbes. 2020;11(2):158\u201371. https:\/\/doi.org\/10.1080\/19490976.2019.1674124.","journal-title":"Gut Microbes"},{"issue":"42","key":"13081_CR8","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.3748\/wjg.v19.i42.7341","volume":"19","author":"VI Reshetnyak","year":"2013","unstructured":"Reshetnyak VI. Physiological and molecular biochemical mechanisms of bile formation. World J Gastroenterol. 2013;19(42):7341\u201360. https:\/\/doi.org\/10.3748\/wjg.v19.i42.7341.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"13081_CR9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00424-013-1364-3","volume":"466","author":"D Jung","year":"2014","unstructured":"Jung D, York JP, Wang L, Yang C, Zhang A, Francis HL, et al. FXR-induced secretion of FGF15\/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway. Pflugers Arch. 2014;466(5):1011\u20139. https:\/\/doi.org\/10.1007\/s00424-013-1364-3.","journal-title":"Pflugers Arch"},{"key":"13081_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mam.2017.06.001","volume":"56","author":"M Li","year":"2017","unstructured":"Li M, Cai SY, Boyer JL. Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med. 2017;56:45\u201353. https:\/\/doi.org\/10.1016\/j.mam.2017.06.001.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"13081_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/1541-7786.MCR-13-0503","volume":"12","author":"E Lozano","year":"2014","unstructured":"Lozano E, Sanchez-Vicente L, Monte MJ, Herraez E, Briz O, Banales JM, et al. Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development. Mol Cancer Res. 2014;12(1):91\u2013100. https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0503.","journal-title":"Mol Cancer Res"},{"key":"13081_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1756-8722-4-41","volume":"4","author":"J Dai","year":"2011","unstructured":"Dai J, Wang H, Shi Y, Dong Y, Zhang Y, Wang J. Impact of bile acids on the growth of human cholangiocarcinoma via FXR. J Hematol Oncol. 2011;4:41. https:\/\/doi.org\/10.1186\/1756-8722-4-41.","journal-title":"J Hematol Oncol"},{"key":"13081_CR13","doi-asserted-by":"publisher","first-page":"105775","DOI":"10.1016\/j.jsbmb.2020.105775","volume":"205","author":"X Zhang","year":"2021","unstructured":"Zhang X, Yang Z, Shi Z, Zhu Z, Li C, Du Z, et al. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls. J Steroid Biochem Mol Biol. 2021;205:105775. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105775.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"13081_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7(8):678\u201393. https:\/\/doi.org\/10.1038\/nrd2619.","journal-title":"Nat Rev Drug Discov"},{"issue":"7785","key":"13081_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang S, Paik D, Yao L, Kim E, Trinath J, Lu J, et al. Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature. 2019;576(7785):143\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1785-z.","journal-title":"Nature"},{"issue":"4","key":"13081_CR16","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.cell.2020.06.029","volume":"182","author":"ES Winkler","year":"2020","unstructured":"Winkler ES, Shrihari S, Hykes BL Jr., Handley SA, Andhey PS, Huang YS, et al. The intestinal Microbiome restricts Alphavirus infection and dissemination through a bile acid-type I IFN Signaling Axis. Cell. 2020;182(4):901\u2013e1818. https:\/\/doi.org\/10.1016\/j.cell.2020.06.029.","journal-title":"Cell"},{"issue":"7790","key":"13081_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","volume":"577","author":"X Song","year":"2020","unstructured":"Song X, Sun X, Oh SF, Wu M, Zhang Y, Zheng W, et al. Microbial bile acid metabolites modulate gut RORgamma(+) regulatory T cell homeostasis. Nature. 2020;577(7790):410\u20135. https:\/\/doi.org\/10.1038\/s41586-019-1865-0.","journal-title":"Nature"},{"issue":"1","key":"13081_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12967-022-03510-8","volume":"20","author":"Z Peng","year":"2022","unstructured":"Peng Z, Ye M, Ding H, Feng Z, Hu K. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer. J Transl Med. 2022;20(1):302. https:\/\/doi.org\/10.1186\/s12967-022-03510-8.","journal-title":"J Transl Med"},{"issue":"2","key":"13081_CR19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.apsb.2021.07.011","volume":"12","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhang H, Liu X, Xue S, Chen D, Zou J, et al. TGR5 deficiency activates antitumor immunity in non-small cell lung cancer via restraining M2 macrophage polarization. Acta Pharm Sin B. 2022;12(2):787\u2013800. https:\/\/doi.org\/10.1016\/j.apsb.2021.07.011.","journal-title":"Acta Pharm Sin B"},{"key":"13081_CR20","doi-asserted-by":"publisher","unstructured":"Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360(6391). https:\/\/doi.org\/10.1126\/science.aan5931.","DOI":"10.1126\/science.aan5931"},{"issue":"D1","key":"13081_CR21","doi-asserted-by":"publisher","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun D, Wang J, Han Y, Dong X, Ge J, Zheng R, et al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 2021;49(D1):D1420\u201330. https:\/\/doi.org\/10.1093\/nar\/gkaa1020.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"13081_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong L, Lu D, Chen R, Lin Y, Zhu H, Zhang Z, et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell. 2022;40(1):70\u2013e8715. https:\/\/doi.org\/10.1016\/j.ccell.2021.12.006.","journal-title":"Cancer Cell"},{"issue":"10","key":"13081_CR23","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","volume":"7","author":"A Jusakul","year":"2017","unstructured":"Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N, et al. Whole-genome and epigenomic landscapes of etiologically distinct subtypes of Cholangiocarcinoma. Cancer Discov. 2017;7(10):1116\u201335. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0368.","journal-title":"Cancer Discov"},{"issue":"4","key":"13081_CR24","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","volume":"142","author":"JB Andersen","year":"2012","unstructured":"Andersen JB, Spee B, Blechacz BR, Avital I, Komuta M, Barbour A, et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology. 2012;142(4):1021\u2013e3115. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.005.","journal-title":"Gastroenterology"},{"issue":"4","key":"13081_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s12072-019-09954-3","volume":"13","author":"KS Ahn","year":"2019","unstructured":"Ahn KS, O\u2019Brien D, Kang YN, Mounajjed T, Kim YH, Kim TS, et al. Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach. Hepatol Int. 2019;13(4):490\u2013500. https:\/\/doi.org\/10.1007\/s12072-019-09954-3.","journal-title":"Hepatol Int"},{"issue":"4","key":"13081_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","volume":"36","author":"L Ma","year":"2019","unstructured":"Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M, et al. Tumor Cell Biodiversity drives Microenvironmental Reprogramming in Liver Cancer. Cancer Cell. 2019;36(4):418\u2013. https:\/\/doi.org\/10.1016\/j.ccell.2019.08.007. 30 e6.","journal-title":"Cancer Cell"},{"issue":"12","key":"13081_CR27","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btr260.","journal-title":"Bioinformatics"},{"issue":"2","key":"13081_CR28","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1021\/pr500920q","volume":"14","author":"G Xie","year":"2015","unstructured":"Xie G, Wang Y, Wang X, Zhao A, Chen T, Ni Y, et al. Profiling of serum bile acids in a healthy Chinese population using UPLC-MS\/MS. J Proteome Res. 2015;14(2):850\u20139. https:\/\/doi.org\/10.1021\/pr500920q.","journal-title":"J Proteome Res"},{"issue":"11","key":"13081_CR29","doi-asserted-by":"publisher","first-page":"e1195","DOI":"10.1371\/journal.pone.0001195","volume":"2","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, Brunet JP, Tamayo P, Golub TR, Mesirov JP. Subclass mapping: identifying common subtypes in independent disease data sets. PLoS ONE. 2007;2(11):e1195. https:\/\/doi.org\/10.1371\/journal.pone.0001195.","journal-title":"PLoS ONE"},{"issue":"1","key":"13081_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019.","journal-title":"Cell Rep"},{"key":"13081_CR31","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, et al. IOBR: Multi-omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and signatures. Front Immunol. 2021;12:687975. https:\/\/doi.org\/10.3389\/fimmu.2021.687975.","journal-title":"Front Immunol"},{"issue":"8","key":"13081_CR32","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","volume":"76","author":"OF Kuzu","year":"2016","unstructured":"Kuzu OF, Noory MA, Robertson GP. The role of cholesterol in Cancer. Cancer Res. 2016;76(8):2063\u201370. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2613.","journal-title":"Cancer Res"},{"key":"13081_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152. https:\/\/doi.org\/10.1186\/1476-4598-12-152.","journal-title":"Mol Cancer"},{"key":"13081_CR34","doi-asserted-by":"publisher","unstructured":"Hu H, Cheng R, Wang Y, Wang X, Wu J, Kong Y, et al. Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47. J Clin Invest. 2023;133(2). https:\/\/doi.org\/10.1172\/JCI153470.","DOI":"10.1172\/JCI153470"},{"key":"13081_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.019.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"13081_CR36","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cmet.2018.12.020","volume":"29","author":"RE Ericksen","year":"2019","unstructured":"Ericksen RE, Lim SL, McDonnell E, Shuen WH, Vadiveloo M, White PJ, et al. Loss of BCAA catabolism during carcinogenesis enhances mTORC1 activity and promotes Tumor Development and Progression. Cell Metab. 2019;29(5):1151\u2013e656. https:\/\/doi.org\/10.1016\/j.cmet.2018.12.020.","journal-title":"Cell Metab"},{"issue":"5","key":"13081_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga AJ, Chow MT, Luster AD. Chemokines and the immune response to cancer. Immunity. 2021;54(5):859\u201374. https:\/\/doi.org\/10.1016\/j.immuni.2021.01.012.","journal-title":"Immunity"},{"issue":"6220","key":"13081_CR38","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. https:\/\/doi.org\/10.1126\/science.1260419.","journal-title":"Science"},{"issue":"1","key":"13081_CR39","doi-asserted-by":"publisher","first-page":"11088","DOI":"10.1038\/s41598-018-29445-z","volume":"8","author":"WS Song","year":"2018","unstructured":"Song WS, Park HM, Ha JM, Shin SG, Park HG, Kim J, et al. Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma. Sci Rep. 2018;8(1):11088. https:\/\/doi.org\/10.1038\/s41598-018-29445-z.","journal-title":"Sci Rep"},{"issue":"4","key":"13081_CR40","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.3892\/ol.2017.6763","volume":"14","author":"S Proungvitaya","year":"2017","unstructured":"Proungvitaya S, Sombattheera S, Boonsiri P, Limpaiboon T, Wongkham S, Wongkham C, et al. Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma. Oncol Lett. 2017;14(4):4943\u20138. https:\/\/doi.org\/10.3892\/ol.2017.6763.","journal-title":"Oncol Lett"},{"issue":"2","key":"13081_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111\u201328. https:\/\/doi.org\/10.1038\/nrgastro.2017.119.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"13081_CR42","doi-asserted-by":"publisher","unstructured":"Xue R, Chen L, Zhang C, Fujita M, Li R, Yan SM et al. Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes. Cancer Cell. 2019;35(6):932\u2009\u2013\u200947 e8. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.007","DOI":"10.1016\/j.ccell.2019.04.007"},{"issue":"1","key":"13081_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2017.05.009","volume":"32","author":"J Chaisaingmongkol","year":"2017","unstructured":"Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM, et al. Common molecular subtypes among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. Cancer Cell. 2017;32(1):57\u2013e703. https:\/\/doi.org\/10.1016\/j.ccell.2017.05.009.","journal-title":"Cancer Cell"},{"key":"13081_CR44","doi-asserted-by":"publisher","unstructured":"Peng X, Chen Z, Farshidfar F, Xu X, Lorenzi PL, Wang Y et al. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. Cell Rep. 2018;23(1):255\u2009\u2013\u200969 e4. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.077","DOI":"10.1016\/j.celrep.2018.03.077"},{"issue":"2","key":"13081_CR45","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41416-021-01418-6","volume":"125","author":"F Wu","year":"2021","unstructured":"Wu F, Liu YW, Li GZ, Zhai Y, Feng YM, Ma WP, et al. Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes. Br J Cancer. 2021;125(2):255\u201364. https:\/\/doi.org\/10.1038\/s41416-021-01418-6.","journal-title":"Br J Cancer"},{"key":"13081_CR46","doi-asserted-by":"publisher","first-page":"994259","DOI":"10.3389\/fimmu.2022.994259","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li X, Long G, Tao Y, Zhou L, Tang J. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma. Front Immunol. 2022;13:994259. https:\/\/doi.org\/10.3389\/fimmu.2022.994259.","journal-title":"Front Immunol"},{"key":"13081_CR47","doi-asserted-by":"publisher","first-page":"108039","DOI":"10.1016\/j.intimp.2021.108039","volume":"99","author":"Z Wang","year":"2021","unstructured":"Wang Z, Du Y. Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining. Int Immunopharmacol. 2021;99:108039. https:\/\/doi.org\/10.1016\/j.intimp.2021.108039.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"13081_CR48","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3724\/abbs.2022125","volume":"54","author":"X Yao","year":"2022","unstructured":"Yao X, Chen B, Wang M, Zhang S, He B, Shi Z, et al. Exploration and validation of a novel ferroptosis-related gene signature predicting the prognosis of intrahepatic cholangiocarcinoma. Acta Biochim Biophys Sin (Shanghai). 2022;54(9):1376\u201385. https:\/\/doi.org\/10.3724\/abbs.2022125.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"4","key":"13081_CR49","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1002\/jcp.30082","volume":"236","author":"J Liang","year":"2021","unstructured":"Liang J, Liu T, Liao J, Zhang L, Zhou M, Xu W, et al. Development and validation of a CpG island methylator phenotype-related prognostic signature for cholangiocarcinoma. J Cell Physiol. 2021;236(4):3143\u201356. https:\/\/doi.org\/10.1002\/jcp.30082.","journal-title":"J Cell Physiol"},{"issue":"2","key":"13081_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/17474124.2022.2029700","volume":"16","author":"Z Wang","year":"2022","unstructured":"Wang Z, Zhang Y, Chen Y, Liu S, Li C, Li X. Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma. Expert Rev Gastroenterol Hepatol. 2022;16(2):181\u201391. https:\/\/doi.org\/10.1080\/17474124.2022.2029700.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"13081_CR51","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1038\/s41467-023-41552-8","volume":"14","author":"AD Ciuta","year":"2023","unstructured":"Ciuta AD, Nosol K, Kowal J, Mukherjee S, Ramirez AS, Stieger B, et al. Structure of human drug transporters OATP1B1 and OATP1B3. Nat Commun. 2023;14(1):5774. https:\/\/doi.org\/10.1038\/s41467-023-41552-8.","journal-title":"Nat Commun"},{"issue":"5","key":"13081_CR52","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/clpt.2012.127","volume":"92","author":"TM Sissung","year":"2012","unstructured":"Sissung TM, Reece KM, Spencer S, Figg WD. Contribution of the OATP1B subfamily to cancer biology and treatment. Clin Pharmacol Ther. 2012;92(5):658\u201360. https:\/\/doi.org\/10.1038\/clpt.2012.127.","journal-title":"Clin Pharmacol Ther"},{"issue":"18","key":"13081_CR53","doi-asserted-by":"publisher","first-page":"22164","DOI":"10.18632\/aging.203502","volume":"13","author":"L Zhi","year":"2021","unstructured":"Zhi L, Zhao L, Zhang X, Liu W, Gao B, Wang F, et al. SLCO1B3 promotes colorectal cancer tumorigenesis and metastasis through STAT3. Aging. 2021;13(18):22164\u201375. https:\/\/doi.org\/10.18632\/aging.203502.","journal-title":"Aging"},{"key":"13081_CR54","doi-asserted-by":"publisher","unstructured":"Horst AK, Najjar SM, Wagener C, Tiegs G. CEACAM1 in Liver Injury, metabolic and Immune Regulation. Int J Mol Sci. 2018;19(10). https:\/\/doi.org\/10.3390\/ijms19103110.","DOI":"10.3390\/ijms19103110"},{"issue":"6","key":"13081_CR55","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nri1864","volume":"6","author":"SD Gray-Owen","year":"2006","unstructured":"Gray-Owen SD, Blumberg RS. CEACAM1: contact-dependent control of immunity. Nat Rev Immunol. 2006;6(6):433\u201346. https:\/\/doi.org\/10.1038\/nri1864.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"13081_CR56","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.neo.2014.05.003","volume":"16","author":"R Ortenberg","year":"2014","unstructured":"Ortenberg R, Galore-Haskel G, Greenberg I, Zamlin B, Sapoznik S, Greenberg E, et al. CEACAM1 promotes melanoma cell growth through Sox-2. Neoplasia. 2014;16(5):451\u201360. https:\/\/doi.org\/10.1016\/j.neo.2014.05.003.","journal-title":"Neoplasia"},{"issue":"2","key":"13081_CR57","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3892\/ol.2018.8835","volume":"16","author":"ZM Han","year":"2018","unstructured":"Han ZM, Huang HM, Sun YW. Effect of CEACAM-1 knockdown in human colorectal cancer cells. Oncol Lett. 2018;16(2):1622\u20136. https:\/\/doi.org\/10.3892\/ol.2018.8835.","journal-title":"Oncol Lett"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13081-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13081-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13081-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T07:04:49Z","timestamp":1729839889000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13081-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["13081"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13081-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"16 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed in stringent adherence to the Declaration of Helsinki and were approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang University School of Medicine (llT20230730A) with informed consent signed by all enrolled patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication have been obtained from all enrolled patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1313"}}